Why availability dates are hard to predict: Even if all trials succeed, the FDA review process takes time
Better outcomes with GLP-1s in those with diabetes and peripheral arterial disease July 29, 2026 Summary: In a propensity-matched observational study of 2,133 pairs of patients with type 2 diabetes and peripheral artery disease, those prescribed GLP-1 receptor agonists had lower five-year rates of death, hospitalization, revascularization, and amputation than those prescribed metformin
The accelerated vascular response observed in BPC-157-treated animal models shortens the window from injury onset to active tissue remodeling, reducing the total recovery timeline relative to non-treated tendons in comparative studies
Oxidative stress and damage is proven to be a large contributor to aging and deterioration in physiological function
and then transported to other tissues such as the brain and heart
Shop Now Dive into Epionces award-winning, medical-grade skincare products designed to enhance cosmetic treatments and promote youthful, radiant skin